Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Sally Bridget Lawlor currently holds 5,122 shares of Quoin Pharmaceuticals, Ltd. (QNRX), valued at approximately $0. This represents their equity stake as Chief Financial Officer.
Based on SEC Form 4 filings, Sally Bridget Lawlor has been a net buyer of QNRX stock. They have purchased $50.0K and sold $0 worth of shares.
Sally Bridget Lawlor's most recent insider trade was on Aug 31, 2026, when they purchased 5,122 shares at $0.00 per share.
Sally Bridget Lawlor serves as Chief Financial Officer at Quoin Pharmaceuticals, Ltd. (QNRX). They have executed 2 insider transactions totaling $50.0K over their tenure at the company.
Sally Bridget Lawlor holds the position of Chief Financial Officer at Quoin Pharmaceuticals, Ltd., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Sally Bridget Lawlor has shown a buying trading pattern, with $50.0K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Sally Bridget Lawlor was on Aug 31, 2026, when they purchased $50.0K worth of QNRX shares. This transaction involved 10,244 shares at $4.88 per share.
Sally Bridget Lawlor currently owns 5,122 shares of Quoin Pharmaceuticals, Ltd. (QNRX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Sally Bridget Lawlor's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Sally Bridget Lawlor has 2 Form 4 filings on record as an insider at Quoin Pharmaceuticals, Ltd..
Set alerts for Sally Bridget Lawlor and 40,000+ other insiders.